Moderna, Inc. (MRNA) FY2024 Annual Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2024-12-31

Swipe to see the full flow
Moderna, Inc. (MRNA) FY2024 Annual Balance SheetBalance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.Current liabilities$2.21 BCurrent assets$8.10 BLiabilities$3.24 BAssets$14.14 BNon-current liabilities$1.04 BEquity$10.90 BGross equity(calculated)$10.91 BNon-current assets$6.04 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInvestmentsCash and cash equivalentsPrepaid expenses and other current assetsAccounts receivable, netInventoryInvestments, non-currentProperty, plant and equipment, netRight-of-use assets, operating leasesOther non-current assetsAccrued liabilitiesAccounts payableOther current liabilitiesDeferred revenueOperating lease liabilities, non-currentOther non-current liabilitiesDeferred revenue, non-currentFinancing lease liabilities, non-currentRetained earningsAdditional paid-in capitalCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated other comprehensive lossAccrued liabilitiesAccrued liabilities$1.43 BCurrent liabilitiesCurrent liabilities$2.21 BAccounts payableAccounts payable$405.00 MCurrent assetsCurrent assets$8.10 BLiabilitiesLiabilities$3.24 BOther current liabilitiesOther current liabilities$221.00 MInvestmentsInvestments$5.10 BAssetsAssets$14.14 BDeferred revenueDeferred revenue$153.00 MCash and cash equivalentsCash and cash equivalents$1.93 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$671.00 MNon-current liabilitiesNon-current liabilities$1.04 BOther non-current liabilitiesOther non-current liabilities$267.00 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$599.00 MEquityEquity$10.90 BDeferred revenue, non-currentDeferred revenue, non-current$58.00 MAccounts receivable, netAccounts receivable, net$358.00 MGross equity (calculated)Gross equity(calculated)$10.91 BFinancing lease liabilities, non-currentFinancing lease liabilities, non-current$39.00 MInventoryInventory$117.00 MNon-current assetsNon-current assets$6.04 BInvestments, non-currentInvestments, non-current$2.49 BProperty, plant and equipment, netProperty, plant and equipment, net$2.20 BRetained earningsRetained earnings$10.05 BRight-of-use assets, operating leasesRight-of-use assets, operating leases$759.00 MOther non-current assetsOther non-current assets$594.00 MAdditional paid-in capitalAdditional paid-in capital$866.00 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$10.00 M
Chart details

Moderna, Inc. (MRNA) FY2024 Annual Balance Sheet

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

Assets
14,142,000,000 US dollars
Current assets
8,099,000,000 US dollars
Non-current assets
6,043,000,000 US dollars
Liabilities
3,241,000,000 US dollars
Current liabilities
2,206,000,000 US dollars
Non-current liabilities
1,035,000,000 US dollars
Equity
10,901,000,000 US dollars
Investments
5,098,000,000 US dollars
Cash and cash equivalents
1,927,000,000 US dollars
Prepaid expenses and other current assets
599,000,000 US dollars
Accounts receivable, net
358,000,000 US dollars
Inventory
117,000,000 US dollars
Investments, non-current
2,494,000,000 US dollars
Property, plant and equipment, net
2,196,000,000 US dollars
Right-of-use assets, operating leases
759,000,000 US dollars
Other non-current assets
594,000,000 US dollars
Accrued liabilities
1,427,000,000 US dollars
Accounts payable
405,000,000 US dollars
Other current liabilities
221,000,000 US dollars
Deferred revenue
153,000,000 US dollars
Operating lease liabilities, non-current
671,000,000 US dollars
Other non-current liabilities
267,000,000 US dollars
Deferred revenue, non-current
58,000,000 US dollars
Financing lease liabilities, non-current
39,000,000 US dollars
Retained earnings
10,045,000,000 US dollars
Additional paid-in capital
866,000,000 US dollars
Preferred stock, $0.0001; 162 shares authorized as of December 31, 2024 and 2023; no shares issued or outstanding at December 31, 2024 and 2023
0 US dollars
Common stock, par value $0.0001; 1,600 shares authorized as of December 31, 2024 and 2023; 386 and 382 shares issued and outstanding as of December 31, 2024 and 2023, respectively
0 US dollars
Accumulated other comprehensive loss
negative 10,000,000 US dollars
Gross equity (calculated)
10,911,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Moderna, Inc. (MRNA) FY2024 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!